|
Market Closed -
London S.E.
11:35:22 2026-11-09 EST
|
5-day change | 1st Jan Change | ||
| 1,925.00 GBX | -1.28% |
|
-6.10% | +1.05% |
| 10-26 | EARNINGS AND TRADING: Quadrise starts strategic review as losses mount | AN |
| 10-26 | Bioventix PLC Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
Company Valuation: Bioventix PLC
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 206.8 | 179.7 | 201 | 229.7 | 143.7 | 100.6 | - |
| Change | - | -13.1% | 11.82% | 14.29% | -37.44% | -30% | - |
| Enterprise Value (EV) 1 | 206.8 | 173.6 | 201 | 223.7 | 138.6 | 80.95 | 95.95 |
| Change | - | -16.06% | 15.76% | 11.3% | -38.03% | -41.6% | 0.29% |
| P/E | 31x | 23.6x | 24.3x | 28.8x | 19.2x | 11.5x | 13.4x |
| PBR | - | 15.2x | - | 19.1x | 12.4x | 7.55x | 8.99x |
| PEG | - | 1.7x | 2.86x | -8.41x | -3.07x | 49.93x | 2.57x |
| Capitalization / Revenue | 18.9x | 15.3x | - | 16.9x | 11x | 6.65x | 7.76x |
| EV / Revenue | 18.9x | 14.8x | - | 16.4x | 10.6x | 6.24x | 7.4x |
| EV / EBITDA | - | 18x | - | 20.7x | 13.7x | 7.91x | 9.56x |
| EV / EBIT | - | 18.7x | - | 20.8x | 14x | 8.02x | 9.75x |
| EV / FCF | - | 23x | - | 26.9x | 19.8x | 10.3x | 13.7x |
| FCF Yield | - | 4.35% | - | 3.72% | 5.06% | 9.74% | 7.32% |
| Dividend per Share 2 | - | 1.26 | - | 1.55 | 1.5 | 1.5 | 1.5 |
| Rate of return | - | 3.65% | - | 3.52% | 5.45% | 9.09% | 7.79% |
| EPS 2 | 1.279 | 1.459 | 1.583 | 1.529 | 1.433 | 1.436 | 1.432 |
| Distribution rate | - | 86.4% | - | 101% | 105% | 104% | 105% |
| Net sales 1 | 10.93 | 11.72 | - | 13.61 | 13.12 | 12.97 | 12.96 |
| EBITDA 1 | - | 9.662 | - | 10.79 | 10.09 | 10.23 | 10.04 |
| EBIT 1 | - | 9.274 | - | 10.77 | 9.904 | 10.09 | 9.839 |
| Net income 1 | 6.731 | 7.674 | 8.372 | 8.097 | 7.584 | 7.615 | 7.506 |
| Net Debt 1 | - | -6.127 | - | -5.999 | -5.079 | -5.265 | -4.625 |
| Reference price 2 | 39.70 | 34.50 | 38.50 | 44.00 | 27.50 | 19.25 | 19.25 |
| Nbr of stocks (in thousands) | 5,209 | 5,209 | 5,220 | 5,220 | 5,225 | 5,225 | - |
| Announcement Date | 10/18/21 | 10/24/22 | 10/30/23 | 10/28/24 | 10/27/25 | 10/26/26 | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14.33x | 7.76x | 10.21x | 7.69% | 136M | |
| 17.43x | 6.68x | 12.81x | 1.71% | 66.7B | |
| 30.07x | 8.27x | 26.77x | 0.07% | 56.88B | |
| 38.45x | 6.84x | 20.45x | 0.85% | 56.53B | |
| 46.55x | 6.14x | 30.16x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.71x | 62.58x | -21.48x | -.--% | 41.59B | |
| 35.87x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 41.46x | 8.08x | 26.8x | -.--% | 33.29B | |
| -69.81x | 13.21x | -71.01x | -.--% | 25.1B | |
| Average | 16.71x | 13.18x | 7.22x | 1.07% | 41B | |
| Weighted average by Cap. | 21.51x | 12.92x | 11.34x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BVXP Stock
- Valuation Bioventix PLC
Select your edition
All financial news and data tailored to specific country editions
